학술논문
The cost-effectiveness of palivizumab in infants with cystic fibrosis in the Canadian setting: A decision analysis model
Document Type
Article
Author
Source
In: Human Vaccines and Immunotherapeutics . (Human Vaccines and Immunotherapeutics, 4 March 2017, 13(3):599-606)
Subject
Language
English
ISSN
2164554X
21645515
21645515